| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.3 |
2e-07 |
| mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.24 |
5e-06 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.25 |
7e-06 |
| mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.21 |
2e-05 |